HFPO-DA
Hexafluoropropylene oxide dimer acid
2,3,3,3-tetrafluoro-2-(1,1,2,2,3,3,3-heptafluoropropoxy)propanoic acid
A perfluoroether carboxylic acid (GenX) developed by DuPont/Chemours as a PFOA replacement for fluoropolymer manufacturing. Federally regulated under EPA's 2024 PFAS NPDWR at MCL 10 ppt; widely detected in U.S. drinking water.
Primary concern: Liver and immune toxicity
Affected organ systems
Health effects
Exposure routes
Vulnerable populations
Overview
Hexafluoropropylene oxide dimer acid (HFPO-DA), marketed by Chemours under the trade name GenX, is a perfluoroether carboxylic acid introduced around 2009–2010 as a replacement for PFOA in fluoropolymer manufacturing. The GenX process is used at the Chemours Fayetteville Works site in North Carolina to produce fluoropolymer resins for cookware coatings, food packaging, semiconductor components, and other industrial applications. Despite manufacturer claims of a shorter biological half-life than PFOA, HFPO-DA is extraordinarily persistent in the environment, mobile in groundwater, and has been detected in 163 U.S. public water systems serving roughly 2.7 million people under EPA's UCMR 5 monitoring. In April 2024 EPA finalized a Maximum Contaminant Level of 10 ppt for HFPO-DA as one of six PFAS regulated under the National Primary Drinking Water Regulation.
Pollution sources
Sources
HFPO-DA enters drinking water primarily through industrial discharges and atmospheric deposition from fluoropolymer manufacturing plants. The two principal U.S. sources are the Chemours Fayetteville Works facility, which contaminated the Cape Fear River and downstream public water systems in southeastern North Carolina (Brunswick County, Wilmington), and the legacy DuPont Washington Works plant in Parkersburg, West Virginia, which has produced detectable contamination in Lubeck PSD (WV), Little Hocking (OH), and other Ohio River communities. UCMR 5 results show the highest concentrations clustering in Kentucky, South Carolina, North Carolina, and the Ohio River valley, with South Point Village (OH) measuring 39.1 ppt average — nearly four times the federal MCL.
Health risks
EPA's 2024 PFAS NPDWR set the HFPO-DA MCL of 10 ppt based on liver toxicity observed in animal studies — the underlying Reference Dose was derived from increased liver weight and hepatocellular hypertrophy in mouse oral dosing studies. HFPO-DA has not been formally classified as a carcinogen by IARC or NTP, but it has been associated with immune suppression, thyroid disruption, and adverse developmental effects in laboratory studies, and crosses the placenta in humans. Chemours-funded studies have reported a human serum elimination half-life on the order of days-to-weeks — much shorter than PFOA — but independent confirmation is limited and the environmental persistence is undiminished.
Effective treatments
Does not remove
NSF certifications
Water treatment
HFPO-DA is removed effectively by granular activated carbon (GAC), anion exchange resin, and high-pressure membranes including reverse osmosis and nanofiltration. Because HFPO-DA is a shorter-chain perfluoroether acid, it adsorbs less strongly to GAC than long-chain PFAS such as PFOA — GAC breakthrough occurs sooner, so utilities meeting the new federal MCL must monitor media life closely and replace it more frequently than for legacy PFAS. Conventional treatment processes — coagulation, sand filtration, disinfection, UV, and ozonation — do not remove it. Boiling concentrates rather than removes it. NSF/ANSI 53 and NSF P473 certify point-of-use filters for PFAS reduction; NSF/ANSI 58 covers RO systems.
Gallery

Related contaminants
Chemistry + classification data sourced from public databases (PubChem, EPA CompTox, IARC monographs); 3D molecular models from 3d.nih.gov where available.